Showing results (1-10 of 82) with videos related to
Sort By:
Pageof 9
Journal of Cellular Physiology|August 10, 2016
Pathophysiology of the Desmo-AdhesomeAntonio Celentano, Michele Davide Mignogna, Michael McCullough, et al.Journal of the American Dental Association (1939)|August 30, 2014
Oral manifestations of phosphatase and tensin homolog hamartoma tumor syndrome: a report of three casesAntonio Celentano, Daniela Adamo, Stefania Leuci, et al.Head & Neck|April 23, 2015
Nodular fasciitis of the tongueAntonio Celentano, Massimo Mascolo, Gaetano De Rosa, et al.Periodontology 2000|May 16, 2019
Oral autoimmune vesicobullous diseases: Classification, clinical presentations, molecular mechanisms, diagnostic algorithms, and managementStefania Leuci, Elvira Ruoppo, Daniela Adamo, et al.Dermatologic Therapy|August 16, 2019
Use of injectable platelet-rich fibrin in the treatment of plasma cell mucositis of the oral cavity refractory to corticosteroid therapy: A case reportRoberta Gasparro, Daniela Adamo, Michele Masucci, et al.Cranio : the Journal of Craniomandibular Practice|August 11, 2020
Lacosamide in trigeminal neuralgia: report of a case refractory to first- and second-generation anticonvulsantsDaniela Adamo, Noemi Coppola, Giuseppe Pecoraro, et al.Pain Medicine (Malden, Mass.)|July 26, 2019
Vortioxetine in the Treatment of Mood Disorders Associated with Burning Mouth Syndrome: Results of an Open-Label, Flexible-Dose Pilot StudyDaniela Adamo, Giuseppe Pecoraro, Massimo Aria, et al.The Journal of Dermatological Treatment|January 9, 2018
Management of reticular oral lichen planus patients with burning mouth syndrome-like oral symptoms: a pilot studyDaniela Adamo, Michele Davide Mignogna, Giuseppe Pecoraro, et al.Therapeutic Advances in Psychopharmacology|September 9, 2021
Vortioxetine as a new frontier in the treatment of chronic neuropathic pain: a review and updateDaniela Adamo, Elena Calabria, Noemi Coppola, et al.Biomolecules|November 27, 2021
Immunocytometric Analysis of Oral Pemphigus vulgaris Patients after Treatment with Rituximab as AdjuvantGiulio Fortuna, Elena Calabria, Massimo Aria, et al.Pageof 9